Quick and convenient authentication technology fro transgenic insert locus
An insertion site and transgene technology, applied in the field of transgene insertion site identification, can solve problems such as sequence difficulties, multi-site integration transgene deletion or rearrangement, limb abnormalities, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0189] Example 1: Identification of integration sites in pEGFP-PLAG1 transgenic mice (Strategy 1)
[0190] The pEGFP-PLAG1 transgenic plasmid was constructed by cloning the fragment containing the complete coding frame of PLAG1 and the first 100 bases of the translation initiation codon into the EcoRI site of the pCMV-EGFP (purchased from Clontech) vector, and its structure is shown in Figure 4 Show. After the plasmid was digested with NsiI, a 3.8 kb fragment was recovered for microinjection.
[0191] After analyzing the distribution of restriction sites in the fragment sequence of the above-mentioned transgenic vector, it was determined that Sau3AI was used as the restriction endonuclease E1 to digest the genome of the transgenic mouse, so the following linker DNA was designed and synthesized (Sau3AI linker was formed after the two strands were annealed):
[0192] Linker 1: 5'-GTA ATA CGA CTC ACT ATA GGG CAC GCG TGGTCG ACG GCC CGG GCT GGT-3' (SEQ ID NO: 2)
[0193] Linker 2...
Embodiment 2
[0207] Example 2: Identification of integration sites in pEGFP-PLAG1 transgenic mice (Strategy 2)
[0208] Design and synthesize the following linker DNA (blunt end linker is formed after the two strands are annealed):
[0209] Linker 1: 5'-GTA ATA CGA CTC ACT ATA GGG CAC GCG TGGTCG ACG GCC CGG GCT GGT-3' (SEQ ID NO: 10)
[0210] Linker 2: 5′-PO 4 -ACC AGC CC-N2H-3'(5'-OH with PO 4 Substitution, 3'-OH with N 2 H substitution) (SEQ ID NO: 11)
[0211] Dissolve in TE or water to 50pmol / μl, take 5μl (equal molar number) and mix before use, cool down naturally to room temperature for 10 minutes at 80°C and anneal.
[0212] Analyze the sequence of the transgenic vector shown in Example 1 to find out a series of restriction endonucleases EcoRV, NruI, PmacI, XmnI, PshAI, BstZ17I that do not cut the vector DNA and produce blunt ends.
[0213] Take 5-10 μg of genomic DNA from transgenic mice, digest with EcoRV, NruI, PmacI, and XmnI in sequence (i.e., digest with one enzyme to ina...
Embodiment 3
[0224] Example 3: Establishment of transgenic mouse lines and identification of transgenic mouse integration sites using the universal vector Inte-vector
[0225] The IAP promoter and the gene KIF18A3 (1st to 11th exons) cDNA sequence are cloned between the XhoI and BamHI sites of the multi-cloning site region of the universal vector Inte-vector (shown in sequence SEQ ID NO: 1), and the The transgenic plasmid was constructed, digested with NotI, and the linearized fragment between the two NotI restriction sites was recovered for transgenesis.
[0226] According to the method described in Example 1, the genome of the transgenic mouse was digested with Sau3AI, and after purification, it was ligated with the linker (same as Example 1)
[0227] According to the general vector sequence, PvuII is the restriction endonuclease E2 at the 5′ end of the carrier, and KpnI is the restriction endonuclease E2 at the 3′ end of the carrier. Two enzyme digestion systems are established, and the...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 